CAT
Caterpillar Inc.
CAT has the edge over MHH overall, supported by stronger modeled upside and lower modeled downside.
MHH
Mastech Digital, Inc.
MHH's outlook is improving despite an expensive valuation.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
MHH Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| Under pressure | |
| Healthy |
MHH's profitability and balance sheet are currently healthy, but its revenue and cash flow are under pressure.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT has the edge over MHH in the historical PE scenario, which offers more potential upside but is not a forecast.
MHH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 9x | $6.26 | — |
| Cheap | 15x | $1.36 | -78% |
| Fair | 20x | $1.84 | -71% |
| Expensive | 44x | $3.97 | -37% |
| Current | 70x | $6.26 | — |
Historical ranges are pointers, not guarantees.
MHH's PE is in its expensive range at 70x. If earnings grow as analysts expect, today's price would be 9.0x next year's earnings, in its cheap range.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
CAT has the edge over MHH on the outlook, with more favorable revenue expectations.
MHH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect MHH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT earned $25.48 per share over the past year, up 31% from the year before.
MHH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.69 | +672% |
| Q3 2026 | $0.09 | +$0.11 |
| Q2 2026 | $0.17 | +183% |
| Q1 2026 | $0.19 | +12% |
| Q4 2025 | $0.05 | -82% |
| Q3 2025 | -$0.02 | +$0.16 |
| Q2 2025 | $0.06 | +$0.39 |
| Q1 2025 | $0.17 | +$0.81 |
| Q4 2024 | $0.28 | +$0.89 |
MHH has the edge over CAT on earnings, with more consistent year-over-year improvement.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over MHH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over MHH on profitability, with a higher operating margin.
MHH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42M | -13% |
| Q2 2026 | $41.4M | -16% |
| Q1 2026 | $41.1M | -15% |
| Q4 2025 | $45.5M | -10% |
| Q3 2025 | $48.5M | -6.4% |
| Q2 2025 | $49.1M | -0.9% |
| Q1 2025 | $48.3M | +3.2% |
| Q4 2024 | $50.7M | +10% |
MHH's revenue has slid since its 2022 peak: $42M last quarter, down 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 0% | -1.7 points |
| Q2 2026 | -0.8% | -0.8 points |
| Q1 2026 | 0.1% | +4 points |
| Q4 2025 | 2.2% | +2.1 points |
| Q3 2025 | 1.7% | -3 points |
| Q2 2025 | 0.1% | -3.4 points |
| Q1 2025 | -3.8% | -3 points |
| Q4 2024 | 0.1% | +15 points |
MHH's operating margin was 0% last quarter, down 1.7 points from the same quarter a year ago.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the edge over MHH on cash flow, with more consistent year-over-year improvement.
MHH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.4M | -61% |
| Q2 2026 | $2.2M | -33% |
| Q1 2026 | -$3.2M | -$119K |
| Q4 2025 | $4.3M | +10% |
| Q3 2025 | $6.3M | +95% |
| Q2 2025 | $3.2M | +358% |
| Q1 2025 | -$3.1M | -$1.5M |
| Q4 2024 | $3.9M | -26% |
MHH still generates free cash flow, though less than at its 2023 peak: $6M over the past year.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over MHH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
MHH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.3% | +155K shares |
| 1 year | +1.9% | +221K shares |
| 3 years | +1.7% | +198K shares |
| 5 years | +1.2% | +141K shares |
| Available history | +8.3% | +934K shares |
MHH has 12M diluted shares, up 1.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q4 2025 | $654,000 |
| Q3 2025 | $1.5M |
| Q2 2025 | $114,000 |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
MHH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -9.5x | Net Cash |
| Q2 2026 | -7.4x | Net Cash |
| Q1 2026 | -6.5x | Net Cash |
| Q4 2025 | -11.0x | Net Cash |
| Q3 2025 | -13.6x | Net Cash |
| Q2 2025 | -6.9x | Net Cash |
| Q1 2025 | -4.3x | Net Cash |
| Q4 2024 | -3.8x | Net Cash |
MHH has the edge over CAT on leverage, with a lower net debt burden relative to earnings.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
MHH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.8 | Neutral |
| Stochastic | 5.7 | Oversold |
MHH's weekly RSI is 37 (neutral) and its Stochastic is 6 (oversold).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT has the edge over MHH on valuation relative to its sector.
MHH PE vs Industrials Sector
| Metric | MHH | Sector median | Relative |
|---|---|---|---|
| PE | 70x | 24x | 189% above |
| PE % | 90 | 58 | 32 pts above |
MHH is trading at 70x earnings, a 189% premium to the Industrials sector's median of 24x.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has the edge over MHH on trend strength, trading above more of its moving averages.
MHH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.60 | 5.2% below |
| 20 week MA | $7.20 | 13% below |
| 50 week MA | $6.95 | 9.9% below |
| 100 week MA | $7.99 | 22% below |
| 200 week MA | $8.91 | 30% below |
MHH is in a downtrend: it's below all five of its weekly moving averages, and 30% below its 200-week average.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over MHH on returns for 2026, with the stronger performance.
MHH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.0 | $16.9 | +54% |
| 2021 | $16.9 | $16.6 | -1.7% |
| 2022 | $16.6 | $12.4 | -25% |
| 2023 | $12.4 | $8.43 | -32% |
| 2024 | $8.43 | $15.0 | +78% |
| 2025 | $15.0 | $7.28 | -51% |
| 2026 YTD | $7.28 | $6.26 | -14% |
MHH has finished lower in four of the last six years. It's down 14% so far in 2026.